Status:
COMPLETED
Altitudes: A Digital Intervention to Support Caregivers
Lead Sponsor:
University of North Carolina, Chapel Hill
Collaborating Sponsors:
North Carolina Department of Health and Human Services
Conditions:
Care Burden
Care Giving Burden
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
The purpose of the present study is to investigate the feasibility, accessibility, and potential clinical benefits of implementing a moderated online social media platform with therapeutic content, Al...
Detailed Description
Purpose: The purpose of the present study is to investigate the feasibility, accessibility, and potential clinical benefits of implementing a moderated online social media platform with therapeutic co...
Eligibility Criteria
Inclusion
- The participants must be a parent, caregiver, or supporter of a young person who is currently receiving treatment from a CSC program for FEP or STEP clinic, on the waitlist to receive services from the CSC, who has recently graduated/discharged from a CSC program, or was referred to the study from the community (via Early Psychosis Interventions of North Carolina (EPI-NC) warm line, community psychiatrist/therapist, or inpatient/outpatient mental health services) where young person is experiencing psychosis but was not referred or enrolled in CSC
- Parent, caregiver, or supporter must be \> 18 years of age
- Participants recruited from NC CSC programs (i.e., OASIS, SHORE, Encompass, Eagle, AEGIS, WeCare2), STEP programs, and the community screening process
- Parent, caregiver, or supporter must have access to internet through a mobile phone, tablet, or computer
Exclusion
- Parent or caregiver is currently engaged in legal action against the loved one experiencing psychosis
- Parent or caregiver does not speak and understand English as the platform, its moderation, interviews, and measures are available only in English
- Parent, caregiver, or supporter is \<18 years of age
Key Trial Info
Start Date :
September 3 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2025
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT06509100
Start Date
September 3 2024
End Date
August 31 2025
Last Update
January 8 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States, 27599